Moderna goes on the patent offensive; Pablo Legorreta doubles down; Is a biotech recovery on the way?; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Another round of major medical conferences is upon us, and Kyle LaHucik is in Barcelona, bringing us live coverage from the European Society of Cardiology Congress. We’ll be posting updates on our website throughout the weekend.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.